Type III Secretion Systems and Bacterial Virulence

Core Idea

Type III secretion systems (T3SS) are needle-like molecular machines that span both membranes of gram-negative pathogens and inject virulence proteins directly into host cells. This system is essential for pathogens like Salmonella and Shigella, allowing them to manipulate host cell signaling and create conditions favorable for invasion and survival.

Explainer

From your study of bacterial protein secretion pathways, you know that gram-negative bacteria face a special challenge: they have two membranes (inner and outer) plus a periplasmic space between them, so getting proteins out of the cell — or into a target cell — requires dedicated molecular machinery. The type III secretion system (T3SS) is one of the most dramatic solutions evolution has produced. It assembles a structure that looks and functions remarkably like a molecular syringe: a basal body spanning both bacterial membranes, connected to an extracellular needle that can puncture the membrane of a host cell and inject proteins directly into its cytoplasm.

The structural similarity between the T3SS and the bacterial flagellum is not coincidental — they share an evolutionary ancestor. Both use a basal body with ring structures embedded in the inner and outer membranes, and both export proteins through a central channel. But where the flagellum exports flagellin subunits to build a motility appendage, the T3SS exports effector proteins — virulence factors designed to hijack the host cell from the inside. The needle itself is about 60–80 nanometers long and only 2–3 nanometers wide in its inner channel, so effector proteins must be at least partially unfolded to pass through. Chaperone proteins in the bacterial cytoplasm keep effectors unfolded and guide them to the secretion apparatus.

Once injected, effector proteins go to work manipulating the host cell's own signaling pathways. Salmonella, for example, injects effectors that reorganize the host cell's actin cytoskeleton, causing the cell membrane to ruffle and engulf the bacterium — essentially tricking a non-phagocytic cell into swallowing it. Other effectors suppress the host's inflammatory response or prevent the bacterium-containing vacuole from fusing with lysosomes. Shigella uses a similar injection strategy but escapes its vacuole entirely, replicating freely in the host cytoplasm and even hijacking actin polymerization to propel itself from cell to cell.

The T3SS is tightly regulated because building and operating the needle complex is energetically expensive, and premature secretion of effectors would waste resources. Bacteria typically activate T3SS gene expression only upon contact with host cells or in response to environmental cues like temperature, pH, or ion concentration that signal they are inside a host. This contact-dependent triggering means the system fires like a loaded weapon — assembled and ready, but only deploying its payload when the needle tip senses a eukaryotic membrane. Understanding the T3SS has become a major focus of antimicrobial research, since disabling the needle without killing the bacterium could disarm pathogens without driving antibiotic resistance.